Felix joined Luxempart in 2023 focusing on investment opportunities in the DACH region.
He started his career at Deutsche Bank’s Corporate Finance Department advising on M&A and ECM transactions. Felix then joined HQ Equita, a German Private Equity Investor focusing on midmarket investments in the DACH region. Before joining Luxempart, he built up the Corporate Finance Department of Patient 21, a German scale-up, and supported the Series C financing round.
During his career, he has gained experience across various sectors including healthcare, industrials, technology, business services, and tourism. Felix holds a Master’s degree in Accounting and Finance from the University of St. Gallen.